Avalo Therapeutics (AVTX) Return on Capital Employed Growth (5y) (2020 - 2026)
Avalo Therapeutics (AVTX) Return on Capital Employed Growth (5y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,681.27 Bn | 66,680.98 Bn | - |
| 2 | Nanobiotix | 1,911.83 Bn | 1,911.77 Bn | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - |
| 4 | BeOne Medicines | 472.75 Bn | 467.96 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.14 Bn | 114.89 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.09 Bn | 61.34 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - |
| 8 | Argenx Se | 55.94 Bn | 50.76 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.52 Bn | 34.51 Bn | 959.66 Mn |
| 10 | Avalo Therapeutics | 401.13 Mn | 343.98 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 18,288.00 |
| Dec 31, 2025 | 13,335.00 |
| Sep 30, 2025 | 7,425.00 |
| Jun 30, 2025 | 7,437.00 |
| Mar 31, 2025 | 13,539.00 |
| Dec 31, 2024 | -1,146.00 |
| Sep 30, 2024 | -11,809.00 |
| Jun 30, 2024 | -20,500.00 |
| Mar 31, 2024 | 11,826.00 |
| Dec 31, 2023 | -5,050.00 |
| Sep 30, 2023 | -4,207.00 |
| Jun 30, 2023 | -28,408.00 |
| Mar 31, 2023 | -25,025.00 |
| Dec 31, 2022 | -34,842.00 |
| Sep 30, 2022 | -42,142.00 |
| Jun 30, 2022 | 14,848.00 |
| Mar 31, 2022 | 53,988.00 |
| Dec 31, 2021 | 35,704.00 |
| Sep 30, 2021 | 33,286.00 |
| Jun 30, 2021 | -1,777.00 |